{"id":"standard-hyponatremia-treatment","safety":{"commonSideEffects":[{"rate":null,"effect":"Osmotic demyelination syndrome (with overly rapid correction)"},{"rate":null,"effect":"Hypernatremia (overcorrection)"},{"rate":null,"effect":"Fluid overload (with hypotonic solutions)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Hyponatremia (low blood sodium) is managed through multiple approaches depending on acuity and cause: acute symptomatic hyponatremia may require hypertonic saline infusion to rapidly raise sodium levels, while chronic hyponatremia is often managed with fluid restriction to allow gradual sodium normalization. The underlying mechanism depends on the specific treatment modality employed, ranging from osmotic correction via saline administration to water balance restoration through fluid intake limitation.","oneSentence":"Standard hyponatremia treatment typically involves fluid restriction and/or sodium supplementation to restore normal serum sodium levels.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:36:19.349Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hyponatremia (symptomatic or severe)"}]},"trialDetails":[{"nctId":"NCT07422948","phase":"NA","title":"Efficacy and Safety of Early Initiation of Midodrine for Control and Prevention of Ascites and Its Related Complications in Acute-on-chronic Liver Failure.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2026-02-05","conditions":"Acute on Chronic Liver Failure","enrollment":113},{"nctId":"NCT06381934","phase":"NA","title":"Validation of New Diagnostic Indices to Simplify Hyponatremia Therapy Assessment in Patients on Thiazide Diuretics","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-05-06","conditions":"Thiazide Associated Hyponatremia","enrollment":136},{"nctId":"NCT07189091","phase":"PHASE4","title":"CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultS","status":"RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2025-10-07","conditions":"Critical Care, Intensive Care, Fluid Accumulation, Fluid and Electrolyte Imbalance","enrollment":640},{"nctId":"NCT04216329","phase":"PHASE1","title":"Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-07-07","conditions":"Gliosarcoma, Newly Diagnosed, Glioblastoma","enrollment":11},{"nctId":"NCT05692726","phase":"","title":"Evaluation of Volume and Electrolyte Balance in Hyponatremia Treatment - a Prospective Observational Trial","status":"RECRUITING","sponsor":"University of Cologne","startDate":"2022-10-15","conditions":"Non-hypervolemic Hyponatremia","enrollment":50},{"nctId":"NCT03557957","phase":"NA","title":"Targeted Correction of Plasma Sodium Levels in Hospitalized Patients With Hyponatremia","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2018-08-20","conditions":"Hyponatremia","enrollment":2278},{"nctId":"NCT06020495","phase":"PHASE3","title":"Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-12-17","conditions":"Hyponatremia","enrollment":260},{"nctId":"NCT00664014","phase":"PHASE2","title":"A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia","status":"COMPLETED","sponsor":"Otsuka Beijing Research Institute","startDate":"2008-05","conditions":"Hypovolemic Hyponatremia","enrollment":241},{"nctId":"NCT05285371","phase":"EARLY_PHASE1","title":"Boluses of Ringer's in Surgical Kids (BRiSK Study)","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2022-02-22","conditions":"Dehydration in Children, Fluid Therapy","enrollment":70},{"nctId":"NCT04483960","phase":"PHASE3","title":"Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Melbourne","startDate":"2020-07-28","conditions":"SARS-CoV-2 Infection (COVID-19)","enrollment":2200},{"nctId":"NCT06171100","phase":"","title":"Low-dose Tolvaptan for Inpatient Hyponatraemia.","status":"RECRUITING","sponsor":"King's College Hospital NHS Trust","startDate":"2024-03-15","conditions":"Hyponatremia, SIADH","enrollment":180},{"nctId":"NCT05904223","phase":"NA","title":"Effect of IN Hospital PCR Based Assessment of Patients With Lower Respiratory Tract Infections on LEngth of Stay","status":"UNKNOWN","sponsor":"Alexander Zoufaly","startDate":"2023-05-10","conditions":"Respiratory Infection","enrollment":302},{"nctId":"NCT05408104","phase":"","title":"Postoperative Tolvaptan Use in Left Ventricular Assist Device Implantation Patients","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2019-03-28","conditions":"Heart Failure, Heart Assist Device, Hyponatremic","enrollment":28},{"nctId":"NCT02614807","phase":"NA","title":"Protein Supplementation in Thiazide-induced Hyponatremia","status":"WITHDRAWN","sponsor":"Ottawa Hospital Research Institute","startDate":"2016-06","conditions":"Hyponatremia, Hypertension, Blood Pressure","enrollment":""},{"nctId":"NCT01386372","phase":"PHASE2","title":"Tolvaptan for In-hospital Hyponatremia","status":"TERMINATED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2011-06","conditions":"Hyponatremia","enrollment":3},{"nctId":"NCT01605357","phase":"PHASE1, PHASE2","title":"Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2012-07","conditions":"Traumatic Brain Injury, Subdural Hematoma, Cerebral Contusion","enrollment":""},{"nctId":"NCT00684164","phase":"PHASE3","title":"Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2008-05","conditions":"Hyponatremia","enrollment":""},{"nctId":"NCT01507727","phase":"PHASE2, PHASE3","title":"Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2012-01","conditions":"Non-hypovolemic Non-acute Hyponatremia","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Standard hyponatremia treatment","genericName":"Standard hyponatremia treatment","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Standard hyponatremia treatment typically involves fluid restriction and/or sodium supplementation to restore normal serum sodium levels. Used for Hyponatremia (symptomatic or severe).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}